Digital image analysis of the distribution of proliferating cell nuclear antigen in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma

被引:12
作者
Lake-Bakaar, G [1 ]
Mazzoccoli, V [1 ]
Ruffini, L [1 ]
机构
[1] Vet Adm Med Ctr, Dept Med 111E, Northport, NY 11768 USA
关键词
hepatitis C; hepatocyte turnover; cirrhosis; proliferating cell nuclear antigen; digital image analysis;
D O I
10.1023/A:1015800126283
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Viral dynamic studies in chronic hepatitis C virus (HCV) infection indicate a significantly shortened survival of virus-infected cells. Since at the steady state of chronic viral infection, the rate of infected cell elimination equals new cell regeneration, this would imply a high rate of hepatocyte turnover in chronic HCV liver disease. We estimated the fraction of regenerating hepatocytes in liver biopsy sections in chronic HCV liver disease, cirrhosis, and hepatocellular carcinoma (HCC). We used antibodies to proliferating cell nuclear antigen (PCNA) to detect proliferating cell nuclei in liver biopsy specimen from controls and patients with chronic hepatitis, cirrhosis, and HCC. We also used bis-benzimide to label fluorescently all hepatocyte nuclei simultaneously. Using digital image analysis, we calculated the area occupied by PCNA-stained hepatocyte nuclei, as a fraction of the total area occupied by fluorescently labeled hepatocyte nuclei (labeling index; LI). Antibody staining was negligible in the control specimen. The mean +/- SE PCNA LI increased from 0.21 +/- 0.1 in chronic hepatitis to 0.63 +/- 0.15 in HCC. There was no significant difference between chronic hepatitis and cirrhosis. The fraction of cells undergoing regeneration is increased in chronic HCV liver disease, HCV-related cirrhosis, and HCC. Increased hepatocyte turnover could provide the link between chronic HCV liver disease and HCC.
引用
收藏
页码:1644 / 1648
页数:5
相关论文
共 29 条
[1]   Use of interferon for prevention of hepatocellular carcinoma in cirrhotic patients with hepatitis B or hepatitis B virus infection [J].
Baffis, V ;
Shrier, I ;
Sherker, AH ;
Szilagyi, A .
ANNALS OF INTERNAL MEDICINE, 1999, 131 (09) :696-701
[2]   Ultrarapid hepatitis C virus clearance by daily high-dose interferon in non-responders to standard therapy [J].
Bekkering, FC ;
Brouwer, JT ;
Leroux-Roels, G ;
Van Vlierberghe, H ;
Elewaut, A ;
Schalm, SW .
JOURNAL OF HEPATOLOGY, 1998, 28 (06) :960-964
[3]   Natural history and pathogenesis of hepatitis C virus related hepatocellular carcinoma [J].
Colombo, M .
JOURNAL OF HEPATOLOGY, 1999, 31 :25-30
[4]   Relationship between hepatocyte proliferative activity and liver functional reserve in human cirrhosis [J].
Delhaye, M ;
Louis, H ;
Degraef, C ;
LeMoine, O ;
Deviere, J ;
Gulbis, B ;
Jacobovitz, D ;
Adler, M ;
Galand, P .
HEPATOLOGY, 1996, 23 (05) :1003-1011
[5]  
Donato MF, 2000, HEPATOLOGY, V32, p361A
[6]  
Edamoto Y, 1996, CANCER, V77, P1787
[7]  
Farinati F, 1996, HEPATOLOGY, V23, P1468
[8]   Viral dynamics of hepatitis C early after orthotopic liver transplantation: Evidence for rapid turnover of serum virions [J].
Fukumoto, T ;
Berg, T ;
Ku, Y ;
Bechstein, WO ;
Knoop, M ;
Lemmens, HP ;
Lobeck, H ;
Hopf, U ;
Neuhaus, P .
HEPATOLOGY, 1996, 24 (06) :1351-1354
[9]  
KATO Y, 1994, CANCER, V74, P2234, DOI 10.1002/1097-0142(19941015)74:8<2234::AID-CNCR2820740805>3.0.CO
[10]  
2-6